Back to search

Article

PRC2 loss impairs small cell lung cancer tumorigenesis and enhances sensitivity to G9a/GLP inhibition

2025-03-31

Abstract excerpt

<title>Abstract</title> <p>Effective targeted therapies for small cell lung cancer (SCLC) remain a significant challenge. Targeting the epigenome to overcome immune evasion and chemoresistance represents a promising strategy to improve treatment outcomes. In this study, we explored the role of Polycomb repressive complex 2 (PRC2), a key transcriptional repressor, by dissecting its structural and enzymatic functio...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1054e793-bc3e-5e72-b296-0a1ca4ada2e9
DOI
10.21203/rs.3.rs-5952196/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
PRC2 loss impairs small cell lung cancer tumorigenesis and enhances sensitivity to G9a/GLP inhibitionDOI 10.21203/rs.3.rs-5952196/v1
Select a neighboring publication to make it the new centre.